Yellow fever vaccine: worthy friend or stealthy foe?

Yellow fever

(2015) Thomas P. Monath et al.   JOURNAL OF CLINICAL VIROLOGY

A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old

(2015)   MEMORIAS DO INSTITUTO OSWALDO CRUZ

An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures

(2015) Renata C. Pereira et al.   VACCINE

Booster dose after 10 years is recommended following 17DD-YF primary vaccination

(2015) Ana Carolina Campi-Azevedo et al.   Human Vaccines & Immunotherapeutics

A DNA Vaccine against Yellow Fever Virus: Development and Evaluation

(2015) Milton Maciel et al.   PLoS Neglected Tropical Diseases

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative

(2015) Glynis Dunn et al.   PLoS Pathogens

Defining Risk Groups to Yellow Fever Vaccine-Associated Viscerotropic Disease in the Absence of Denominator Data

(2014) Stephen J. Seligman et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

(2014) Ana Carolina Campi-Azevedo et al.   BMC INFECTIOUS DISEASES

Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms

(2014) Sonia Berrih-Aknin et al.   JOURNAL OF AUTOIMMUNITY

Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies

(2014) Jean-Laurent Casanova et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Risk groups for yellow fever vaccine-associated viscerotropic disease (YEL-AVD)

(2014) Stephen J. Seligman   VACCINE

Yellow fever vaccine-associated adverse events following extensive immunization in Argentina

(2014) Cristián Biscayart et al.   VACCINE

Pathophysiologic and Transcriptomic Analyses of Viscerotropic Yellow Fever in a Rhesus Macaque Model

(2014) Flora Engelmann et al.   PLoS Neglected Tropical Diseases

Safety profile of the yellow fever vaccine Stamaril®: a 17-year review

(2013) Pascale Cottin et al.   Expert Review of Vaccines

Yellow Fever Outbreak in Sudan

(2013) Lewis Markoff   NEW ENGLAND JOURNAL OF MEDICINE

Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009

(2013) Eduardo Stramandinoli Moreno et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010

(2013) J.G. Breugelmans et al.   VACCINE

Review of the risks and benefits of yellow fever vaccination including some new analyses

(2012) Thomas P Monath   Expert Review of Vaccines

An Inactivated Cell-Culture Vaccine against Yellow Fever

(2011) Thomas P. Monath et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adverse event reports following yellow fever vaccination

(2008) Nicole P. Lindsey et al.   VACCINE

Lifetime course of myasthenia gravis

(2007) David Grob et al.   MUSCLE & NERVE